ea0070aep596 | Pituitary and Neuroendocrinology | ECE2020
Pivonello Rosario
, Tabarin Antoine
, Colao Annamaria
, Kaltsas Gregory
, Gonzalez-Molero Inmaculada
, Neggers Sebastian
, Venegas Moreno Eva
, Kocjan Tomaz
, Karges Wolfram
, Krzyzanowska-Mittermayer Katarzyna
, Heck Ansgar
, Eden Engstrom Britt
, Marques Ruben
, O’Brien Eamonn
, Manne Shobha
, Vincenzi Beatrice
, Schöfl Christof
Introduction: Results of the first European real-world evidence from retrospective cohort of ACRONIS study previously confirmed the efficacy and tolerability of LA-PAS in heavily pre-treated, uncontrolled acromegaly patients. Here, we report results of the second interim analysis reflecting the prospective cohort.Methods: Patients who were treated with LA-PAS for ≥6 months were included in this analysis. The primary objective was to document treatm...